FindTrial
Sign In

Canceled by the investigator. Effect of esketamine on rebound pain after nerve block

Clinical study of perioperative multimodal analgesia in patients undergoing orthopedic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065640
Enrollment
Unknown
Registered
2022-11-10
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperation pain

Interventions

Group C:Sufentanil
group S:Sufentanil + ketamine

Sponsors

The Third Affiliated Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: In this study, 100 patients who underwent shoulder arthroscopy in the Third Hospital of Hebei Medical University after proper preoperative preparation were selected. ASA Grade I to II, age 18-80 years.

Exclusion criteria

Exclusion criteria: Peripheral nerve injury or lesion; History of long-term use of analgesics for chronic pain; History of psychotropic drug use; History of alcohol abuse; History of opioid allergy; Lactating and pregnant women; Regional block contraindications, esketamine contraindications, diabetic patients; Patients who do not wish to participate in the study.

Design outcomes

Primary

MeasureTime frame
rebound pain;Duration of sensory and motor nerve block;Postoperative opioid consumption;the satisfaction of patients;Blood Cytokines;Numerical Rating Scale (NRS);Patient Recovery Quality Score;anesthesia related complication;PONV;P atients experiencing a sleep disturbance;sleep disturbances;—

Countries

China

Contacts

Public ContactQiujun Wang

The Third Hospital of Hebei Medical University

wangqiujunsy@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026